|1.||Hovda, Knut Erik: 5 articles (01/2015 - 01/2005)|
|2.||McMartin, K E: 5 articles (12/2013 - 01/2001)|
|3.||Jacobsen, Dag: 4 articles (11/2012 - 10/2002)|
|4.||Brent, Jeffrey: 4 articles (06/2010 - 01/2002)|
|5.||Pelclova, Daniela: 3 articles (01/2015 - 12/2014)|
|6.||Navratil, Tomas: 3 articles (01/2015 - 12/2014)|
|7.||Zakharov, Sergey: 3 articles (01/2015 - 12/2014)|
|8.||Purssell, Roy A: 3 articles (06/2011 - 07/2008)|
|9.||Kennedy, James R: 3 articles (06/2011 - 07/2008)|
|10.||Lepik, Katherine J: 3 articles (06/2011 - 07/2008)|
12/01/2014 - "Recommendations that were issued for hospital triage of fomepizole administration allowed conservation of valuable antidote in this massive poisoning outbreak for those patients most in need."
01/01/2012 - "There are few published cases worldwide of EG poisoning in children managed with fomepizole. "
07/01/2011 - "Fomepizole is the antidote of choice in toxic alcohol poisonings. "
09/01/2010 - "These results indicate that the mechanism for the target organ toxicity results from metabolites of DEG, and not DEG itself nor formation of EG from DEG, and that fomepizole may be a useful antidote for treating DEG poisoning."
09/17/2009 - "Fomepizole for toxic alcohol poisoning."
|2.||Body Weight (Weight, Body)
01/01/2015 - "To inhibit ADH3-mediated retinol metabolism, 10 μg 4-methylpyrazole (4-MP)/g of body weight was administered to mice treated with CCl4 or subjected to BDL. "
01/01/1980 - "The injection of acetate (20 mmol/kg body weight) increased the liver PPi to 0.157 +/- 0.075 mumol/g in 15 min. The alcohol dehydrogenase inhibitor 4-methylpyrazole blocked the accumulation of acetate and the increase in PPi was prevented. "
07/01/1989 - "A 50-mg/ml solution of 4-methylpyrazole in propylene glycol was administered iv as follows: initial treatment, 20 mg/kg of body weight; at 17 hours after admission, 15 mg/kg; at 25 hours after admission, 5 mg/kg. By 24 hours after admission, all dogs had clinical and metabolic improvement. "
09/01/1985 - "Time course experiments and dose-response experiments indicated that an increase in the microsomal oxidation of alcohols could be observed 24 hr after a single treatment with 200 mg/kg body weight of either pyrazole or 4-methylpyrazole, and after 2 or 3 days of treatment with 50 mg/kg of either of these compounds. "
01/01/1998 - "4-Methylpyrazole was found to inhibit both of these processes in vitro and when administered (90 mg kg-1 body weight) to rats, 2 hours prior to 1,3-difluoro-2-propanol, eliminated signs of poisoning, prevented (-) erythrofluorocitrate synthesis, and markedly decreased citrate and fluoride accumulation in vivo. "
08/01/1985 - "In particular all three agents produced unusual heart defects (dilated ductus arteriosus and dilated aortic arch) not seen with other agents, as well as ventral polydactyly, a rarely seen defect, suggesting teratogenic action by a common mechanism or component; 4-methylpyrazole, an alcohol dehydrogenase inhibitor, provided significant protection against 2-ME. "
09/01/2010 - "Treatment with fomepizole blocked the formation of HEAA and DGA and the development of metabolic acidosis and the kidney and liver toxicity. "
07/01/2008 - "2) The stable patient, with less metabolic acidosis and no visual disturbances, should be given buffer and fomepizole. "
04/01/2008 - "The evidence that metabolic acidosis affects outcomes and thus warrants correction is considered and we provide management guidance including extracorporeal removal and fomepizole therapy."
02/01/1997 - "Given 4-methylpyrazole (4-MP), an ADH inhibitor, the acidosis resolved, the patient recovered and was discharged without sequelae. "
06/01/2002 - "Case reports and 1 prospective trial have shown that, in the absence of both renal dysfunction and significant metabolic acidosis, the use of fomepizole should obviate the need for hemodialysis. "
|1.||Ethylene Glycol (Monoethylene Glycol)
|3.||Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))
|5.||Citric Acid (Citrate)
|7.||Mercaptoethanol (2 Mercaptoethanol)
|8.||Ethanol (Ethyl Alcohol)
|9.||formic acid (formate)
|1.||Renal Dialysis (Hemodialysis)
|2.||Intensive Care (Surgical Intensive Care)
|4.||Medication Errors (Medication Error)